Evidence map›Paper›PMID 35673914›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[TSPAN8 is involved in lipid metabolism in non-alcoholic fatty liver disease in mice].

J Zhang, W Xue, S Zhang, Y Zhu, C Yang, Y Gao, L Shi, W Huang

Open access · greenAbstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. [Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

J ZhangDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
W XueDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
S ZhangDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Y ZhuDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
C YangDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Y GaoDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
L ShiDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
W HuangDepartment of Infectious Diseases, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
The Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the changes of tetraspanin 8 (TSPAN8) expression levels and its role in lipid metabolism during the development of non-alcoholic fatty liver disease (NAFLD).

methodsThirty male C57BL/6J mice were randomly divided into normal diet group and high-fat diet (HFD) group (

resultsWestern blotting showed that compared with that in mice with normal feeding, the expression of TSPAN8 was significantly decreased in the liver tissues of mice with HFD feeding for 3 and 6 months (

conclusionTSPAN8 is involved in lipid metabolism in NAFLD, and overexpression of TSPAN8 may inhibit cellular lipid deposition by reducing the expression of FATP5.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsDiet, High-FatFatty Acids, NonesterifiedLipid MetabolismLiverMaleMiceMice, Inbred C57BLRNA, MessengerFatty Acids, NonesterifiedRNA, Messengerlipid metabolismnon-alcoholic fatty liver diseasetetraspanin 8

Identifiers

PMID35673914
PMCPMC9178638
OpenAlexW4282921436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.